Necrostatin-1 (Nec-1), a specific RIP1 kinase inhibitor, has been used to block the necroptotic RIP1/RIP3/MLKL pathway and has been shown to be effective in several neurological diseases [51, 52]. Here, RIPK1 is linked to nervous system disorder.